The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: Implications for tuberculin testing

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 8, 1999, Pages 681-688

  Klein, Robert S ^a,f   Flanigan, T ^b   Schuman, P ^c   Smith, D ^d   Vlahov, D ^e   Schoenbaum, E E ^g   Burk, R D ^g   Greenberg, B ^g   Demas, P ^g   Carpenter, C ^g   Mayer, K ^g   Cu Uvin, S ^g   Mileno, M ^g   Boland, R ^g   Peipert, J ^g   Stein, M ^g   Rich, J ^g   Rompalo, A ^g   Solomon, L ^g   Anderson, J ^g   Munoz A ^g   Nelson, K ^g   Margolick, J ^g   Shah, K ^g   Gleghorn, A ^g   Graham, N ^g   Sobel, J ^g   Christensen, C ^g   Brown, W ^g   Ohmit, S ^g   Lancaster, W D ^g   Eyler, A ^g   Warren, D ^g   Duerr, A ^g   Moore, J ^g   Peterson, B ^g   Holmberg, S ^g   Schrager, L K ^g   Unger, B ^g   Melnick, S L ^g   McKinlay, S ^g   Mitchell, H ^g   Kalish, L ^g   Barkin, S ^g   Tinajero, A ^g   Jones, D ^g   Alperin, S ^g   more..

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f MONTEFIORE MEDICAL CENTER   (United States)

^g NONE

Author keywords

Delayed type hypersensitivity testing; HIV; Skin tests; Tuberculin testing; Women

Indexed keywords

MUMPS VACCINE; TETANUS TOXOID; TUBERCULIN;

ADULT; ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOASSAY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN TEST; TUBERCULIN TEST;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CANDIDA; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; HYPERSENSITIVITY, DELAYED; MIDDLE AGED; MUMPS; ODDS RATIO; SKIN TESTS; STATISTICS, NONPARAMETRIC; TETANUS; TUBERCULOSIS;

EID: 20244366361     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Gottlieb M S, Groopman J E, Weinstein W M, Fahey J L, Detels R. The acquired immunodeficiency syndrome. Ann Intern Med 1983; 99: 208-22C.
2. Fauci A S, Macher A M, Longo D L, et al. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 1984; 100: 92-106.
3. Colebunders R L, Lebughe I, Nzila N, et al. Cutaneous delayed-type hypersensitivity in, patients with human immunodeficiency virus infection in Zaire. J Acquir Immune Defic Syndr 1989; 2: 576-578.
4. Borleffs J C C, Vrehen H M, Bosboom-Kalsbeek K C, Hoepelman A M, Schuurman H, Gme ig-Meyling F H J. Delayed-type hypersensitivity skin testing in patients with HIV infection. AIDS 1991; 5: 110-112.
5. Graham N M, Nelson K E, Solomon L, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-seropositive and -seronegative intravenous drug users. JAMA 1992; 267: 369-373.
6. Zeballos R S, Cavalcante N, Freire C A R, et al. Delayed hypersensitivity skin tests in prognosis of human immunodeficiency virus infection. J Clin Lab Anal 1992; 6: 119-122.
7. Birx D L, Brundage J, Larson K, et al. The prognostic utility of delayed-type hypersensitivity skin testing in the evaluation of HIV-infected patients. J Acquir Immune Defic Syndr 1993; 6: 1248-1257.
8. Markowitz N, Hansen N, Wilcosky T C, et al. Tuberculin and anergy testing in HIV-seropos five and HIV-seronegative persons. Ann Intern Med 1993; 119: 185-193.
9. Gordin F M, Hartigan P M, Klimas N G, Zolla-Pasner S B, Simberkoff M S, Hamilton J D. Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. J Infect Dis 1994; 169: 893-897.
10. Huebner R E, Schein M F, Hall C A, Barnes S A. Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis. Clin Infect Dis 1994; 19: 26-32.
11. Caiaffa W T, Graham N M H, Galai N, Rizzo R T, Nelson K E, Vlahov D. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Arch Intern Med 1995; 155: 2111-2117.
12. Chin D P, Osmond D, Page Shafer K, et al. Reliability of anergy skin testing in persons with HIV infection. Am J Respir Crit Care Med 1996; 153: 1982-1984.
13. Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR Morb Mortal Wkly Rep 1991; 40(RR-5): 27-33.
14. Markowitz N, Hansen N I, Hopewell P C, et al. Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med 1997; 126: 123-132.
15. Girardi E, Antonucci G, Ippolito G, et al. Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients. Arch Intern Med 1997; 157: 797-800.
16. Smith D K, Warren D L, Vlahov D, et al. Design and baseline participant characteristics of the human immunodeficiency virus epidemiology research (HER) study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997; 146: 459-469.
17. Palmer D L, Reed W P. Delayed hypersensitivity skin testing. II. Clinical correlates and anergy. J Infect Dis 1974; 130: 138-143.
18. Whalen C C, Johnson J L, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 801-808.
19. Gourevitch M N, Hartel D, Schoenbaum E E, Klein R S. Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med 1996; 154: 1029-1033.
20. Johnson M P, Coberly J S, Clermont H C, et al. Tuberculin skin test reactivity among adults infected with human immunodeficiency virus. J Infect Dis 1992; 166: 194-198.
21. Selwyn P A, Hartel D, Lewis V A, et al. Prospective study of the risk of tuberculosis in intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
22. Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR Morb Mortal Wkly Rep 1989; 38: 236-238, 243-250.
23. Miller S D, Jones H E. Correlation of lymphocyte transformation with tuberculin skin-rest sensitivity. Am Rev Respir Dis 1973; 107: 530-538.
24. Jones H E, Reinhardt J H, Greenberg J. Immunological significance of small (1-10 mm) skin test reactions. J Invest Dermatol 1974; 62: 544.
25. Centers for Disease Control and Prevention. Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. MMWR Morb Mortal Wkly Rep 1997; 46 (RR-15): 1-10.